Is GPT Healthcare a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that GPT Healthcare Ltd is a good quality company .

Is GPT Healthcare undervalued or overvalued?

The key valuation ratios of GPT Healthcare Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is GPT Healthcare share price return in the past 10 years?

Data is not available for this company

Is GPT Healthcare a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of GPT Healthcare Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

GPT Healthcare Ltd - Stock Valuation and Financial Performance

Name: GPT Healthcare
Brand: GPT Healthcare

BSE: 544131 | NSE: GPTHEALTH | Hospital & Healthcare Services | Small Cap

Place order

GPT Healthcare Share Price

₹166.95 5.85 3.63%
as on 21-Nov'24 16:59

10 Year X-Ray of GPT Healthcare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	0%	0%	0%	11.8%	16.1%	13%	17.1%	25.6%	26.9%	32.6%	-
Value Creation Index ⓘ	NA	NA	NA	-0.2	0.2	-0.1	0.2	0.8	0.9	1.3	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	146	172	212	243	337	361	400	400
Sales YoY Gr.	-	NA	NA	NA	17.5%	23.3%	14.6%	39%	7%	10.8%	-
Adj EPS ⓘ	0	0	0	1.4	2.8	2.1	3.8	5.2	4.8	5.8	5.8
YoY Gr.	-	NA	NA	NA	98.6%	-27%	85.9%	35.8%	-6.9%	20.5%	-
BVPS (₹) ⓘ	0	0	0	18.7	21.5	16.1	17.5	19.8	20.7	26.6	27.8
Adj Net Profit ⓘ	0	0	0	7.7	15.2	11.1	20.6	41.5	38.7	47.8	48
Cash Flow from Ops. ⓘ	0	0	0	22.3	31.7	41.5	43	66	66.4	68.8	-
Debt/CF from Ops. ⓘ	0	0	0	3.5	2.8	2.7	2.9	1.5	1	0.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	18.4%	18.1%	10.8%
Adj EPS ⓘ	NA	15.6%	15%	20.5%
BVPSⓘ	NA	4.3%	15.1%	28.7%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	7.6	14	9.2	15.8	28.4	23.9	24.9	21.4
Op. Profit Mgn % ⓘ	17.7	21.2	17	20.2	21.9	20.6	22	20.8
Net Profit Mgn % ⓘ	5.2	8.8	5.2	8.5	12.3	10.7	12	11.9
Debt to Equity ⓘ	0.8	0.8	0.9	0.9	0.6	0.4	0.1	-
Working Cap Days ⓘ	0	105	114	121	89	78	68	18
Cash Conv. Cycle ⓘ	0	-30	-25	-21	-14	-14	-13	1

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 18.13%

Net Profit is growing at healthy rate in last 3 years 15.03%

Return on Equity has declined versus last 3 years average to 21.40%

Sales growth is not so good in last 4 quarters at 2.26%

Latest Financials - GPT Healthcare Ltd.

	Standalone	Consolidated
TTM EPS (₹)	5.8	5.1
TTM Sales (₹ Cr.)	400	337
BVPS (₹.) ⓘ	27.8	0
Reserves (₹ Cr.) ⓘ	146	78
P/BV ⓘ	5.79	0.00
PE ⓘ	27.67	31.70

From the Market
52 Week Low / High (₹)	129.00 / 219.70
All Time Low / High (₹)	129.00 / 219.70
Market Cap (₹ Cr.)	1,322
Equity (₹ Cr.)	82.1
Face Value (₹)	10
Industry PE ⓘ	40.2

Management X-Ray of GPT Healthcare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of GPT Healthcare

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of GPT Healthcare

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	146	172	212	243	337	361	400
Operating Expenses ⓘ	120	136	176	194	264	287	312
Manufacturing Costs	58	63	81	79	110	132	143
Material Costs	27	31	38	57	87	76	83
Employee Cost	27	31	42	42	54	62	69
Other Costs ⓘ	9	11	14	15	13	17	18
Operating Profit ⓘ	26	36	36	49	74	74	88
Operating Profit Margin (%)	17.6%	21.0%	16.9%	20.2%	21.9%	20.6%	21.9%
Other Income ⓘ	4	3	4	6	5	6	5
Interest ⓘ	10	10	14	14	11	9	7
Depreciation ⓘ	8	9	11	12	14	15	18
Exceptional Items ⓘ	0	0	0	0	0	0	0
Profit Before Tax ⓘ	11	20	15	29	54	56	68
Tax ⓘ	3	5	4	8	12	17	20
Profit After Tax	8	15	11	21	42	39	48
PAT Margin (%)	5.2%	8.7%	5.2%	8.7%	12.3%	10.8%	11.9%
Adjusted EPS (₹)	1.4	2.8	2.0	3.9	5.2	4.9	5.8
Dividend Payout Ratio (%)	0%	0%	0%	67%	134%	82%	60%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	101	116	127	134	158	165	218
Share Capital ⓘ	18	18	58	58	80	80	82
Reserves ⓘ	83	98	69	76	78	85	136
Minority Interest	0	0	0	0	0	0	0
Debt	60	79	103	104	76	42	6
Long Term Debt	48	69	96	102	72	40	4
Short Term Debt	11	10	7	2	3	2	2
Trade Payables	23	23	33	26	29	33	37
Others Liabilities ⓘ	32	29	42	47	57	86	84
Total Liabilities ⓘ	216	247	305	311	320	327	346
Fixed Assets
Gross Block	169	180	260	266	279	296	306
Accumulated Depreciation	16	24	34	46	59	68	81
Net Fixed Assetsⓘ	153	156	226	220	220	228	224
CWIP ⓘ	20	33	2	0	1	3	6
Investmentsⓘ	0	0	1	1	10	13	30
Inventories	4	5	6	6	7	9	8
Trade Receivables	12	11	17	17	13	21	24
Cash Equivalents	0	1	1	5	9	9	9
Others Assetsⓘ	26	41	52	61	59	44	43
Total Assets ⓘ	216	247	305	311	320	327	346

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	22	32	41	43	66	66	69
PBT ⓘ	11	20	15	29	54	56	68
Adjustment ⓘ	15	17	22	21	20	19	22
Changes in Working Capital ⓘ	-1	-3	5	-9	5	2	-6
Tax Paid ⓘ	-3	-3	0	3	-13	-10	-15
Cash Flow From Investing Activity ⓘ	-6	-31	-54	-16	-5	5	-25
Capex	-13	-25	-47	-5	-10	-8	-19
Net Investments	0	0	0	0	-10	-5	-22
Others ⓘ	6	-6	-8	-11	15	18	16
Cash Flow From Financing Activityⓘ	-16	0	12	-22	-57	-73	-49
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	40
Net Proceeds from Borrowing ⓘ	-6	12	29	11	-29	-30	-53
Interest Paid ⓘ	-10	-10	-14	-14	-11	-8	-5
Dividend Paid ⓘ	0	0	0	-13	-17	-32	-24
Others ⓘ	0	-2	-3	-6	0	-4	-7
Net Cash Flow ⓘ	0	1	-1	4	3	-2	-5

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	7.52	13.87	10.81	23.34	33.05	24.11	24.89
ROCE (%)	11.78	16.07	13.04	17.14	25.56	26.93	32.61
Asset Turnover Ratio	0.68	0.74	0.77	0.79	1.07	1.12	1.19
PAT to CFO Conversion(x)	2.75	2.13	3.73	2.05	1.57	1.69	1.44
Working Capital Days
Receivable Days	31	25	24	26	17	17	21
Inventory Days	10	9	10	10	7	8	8
Payable Days	318	276	266	188	114	150	156

GPT Healthcare Ltd Stock News

GPT Healthcare Ltd FAQs

What is the share price of GPT Healthcare?

Company share prices are keep on changing according to the market conditions. The closing price of GPT Healthcare on 21-Nov-2024 16:59 is ₹166.9.

What is the market cap of GPT Healthcare?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of GPT Healthcare stood at ₹1,321.9.

What is the P/E ratio of GPT Healthcare?

The latest P/E ratio of GPT Healthcare as of 21-Nov-2024 16:59 is 27.67.

What is the P/B ratio of GPT Healthcare?

The latest P/B ratio of GPT Healthcare as of 21-Nov-2024 16:59 is 5.79.

What is the 52-week high and low of GPT Healthcare?

The 52-week high of GPT Healthcare is ₹219.7 and the 52-week low is ₹129.0.

What is the TTM revenue of GPT Healthcare?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of GPT Healthcare is ₹400.2 ( Cr.) .

About GPT Healthcare Ltd

GPT Healthcare Limited was originally incorporated as ‘Jibansatya Printing House Private Limited’, a private limited company under the Companies Act, 1956 on August 17, 1989 at Kolkata, West Bengal. The name of the Company was subsequently changed to ‘GPT Healthcare Private Limited’ so that the name of the Company is in consonance with the main objects of the Memorandum of Association in relation to the proposed business activities to be carried out by the Company. A fresh certificate of incorporation was issued by the RoC on March 31, 2005. Thereafter, pursuant to a special resolution passed by its shareholders on September 3, 2021, the Company was converted to a public limited company and its name was changed to ‘GPT Healthcare Limited’. A fresh certificate of incorporation consequent to change of name was issued by the RoC on September 15, 2021.

GPT Healthcare is one of the key regional corporate healthcare companies in Eastern India in terms of number of beds and hospitals as of Fiscal Year 2023. The Principal activities of the company include operation of multidisciplinary private hospitals and pharmacies. The company operates a chain of mid-sized full service hospitals under the brand and provides integrated healthcare services, with a focus on secondary and tertiary care. As of September 30, 2023, the company operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura. It offers a comprehensive range of healthcare services across many specialties and super specialties, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology. Each of its hospitals also provides integrated diagnostic services and pharmacies that cater to its patients.

The company strategically focuses on the relatively under-penetrated healthcare market in Eastern India where it has presence in three cities which has provided it an understanding of regional nuances, patient culture and the mindset of medical professionals and where there is under-penetration of quality and affordable healthcare services.

Business area of the company

The company is engaged in the business of providing healthcare services. The company operates a chain of mid-sized full service hospitals under the brand and provides integrated healthcare services, with a focus on secondary and tertiary care.

Awards, accreditations or recognitions

2016: Surgical Review Corporation accredited its hospital in Salt Lake, West Bengal as Centre for Excellence-Metabolic / Bariatric Surgery.
2020: National Accreditation Board for Testing and Calibration Laboratories accredited its Dum Dum Hospital with ISO 15189:2012 for ‘Medical Laboratories - Requirements for Quality and Competence’.
2020: ILS Hospitals and the Company were awarded the ‘Sanmarg Business Award 2020’ in the category of ‘Medium Scale Services & Trade’.
2020: National Board of Exams provided provisional accreditation to the department of Minimal Access Surgery at its hospital in Salt Lake City, West Bengal to provide post graduate training facilities for FNB - Minimal Access Surgery Programme.
2021: National Accreditation Board for Hospitals and Healthcare Providers provided a certificate of accreditation to its Dum Dum Hospital for complying with NABH Accreditation Standards for Hospitals.
2021: National Accreditation Board for Hospitals and Healthcare Providers provided a certificate of accreditation to its Agartala Hospital for complying with NABH Accreditation Standards for Hospitals.
2021: Its Agartala Hospital was awarded the ‘AHPI Award 2021’ in ‘Excellence for Community Engagement’ from the Association of Healthcare Providers (India).
2021: ILS Hospitals was awarded the ‘Iconic Healthcare Summit & Awards 2021’ by Topgallant Media.
2022: Its Salt Lake Hospital was awarded and received a certificate of honour for ‘Excellence in Customer Care & Support’ at the ‘ABP Ananda Swashthya Samman 2022’.
2022: ILS Hospitals was awarded and received a certificate of honour for ‘Outstanding Hospital Chain at the ‘ABP Ananda Swasthya Samman 2022’.
2023 National Accreditation Board for Testing and Calibration Laboratories accredited its Agartala Hospital with ISO 15189:2012 for ‘Medical Laboratories - Requirements for Quality and Competence’.

History and milestones

1989: Incorporation of the Company.
2000: Company started the hospital business in Salt Lake, West Bengal.
2005: Tantia Medical Services Private Limited sold its nursing home business to the Company on a going concern basis.
2008: Company signed lease agreement for its multi-specialty Agartala Hospital.
2011: Commissioned its Agartala Hospital with a capacity of 205 beds with a Nursing School.
2013: Commissioned its Dum Dum Hospital.
2016: Its Dum Dum Hospital received permission to provide kidney transplantation service.
2019: Commissioned its Howrah Hospital.
2021: Initiated B.Sc Nursing Programme with an intake capacity of 45 students in its Agartala Hospital.
2021: Signed a lease agreement for a new hospital in Ranchi on September 17, 2021.
2023: Signed a memorandum of understanding for the construction and finishing of a hospital building at Raipur on January 16, 2023.
2023: Signed a cancer care department management agreement to set up and operate the cancer care department at its Agartala Hospital on September 1, 2023.